Recall Record

Allentown, PA, United States

B. Braun Medical, Inc. recalls

62 recalls recorded since 2018, most recently on 19 August 2026. 36 are listed as ongoing. Status and classification are as published by the FDA.

Recalls62
Ongoing (FDA)36
Terminated or completed26
Class I (FDA)14

Ongoing Class I Drugs

Recall started
19 August 2026
Reason
Presence of Particulate Matter: particulate matter identified as iron oxide, inorganic material, cellulose cotton fiber or polystyrene
Distribution
Nationwide within the United States
Initiated
Voluntary: Firm initiated
Recall number
D-0869-2026

Ongoing Class I Drugs

Recall started
12 August 2026
Reason
Presence of Particulate matter.
Distribution
U.S. Nationwide
Initiated
Voluntary: Firm initiated
Recall number
D-0832-2026

Ongoing Class II Medical devices

Recall started
4 August 2026
Reason
Specific lots of Discofix Stopcock Sets recalled due to an incorrect expiration date printed on the carton shipper label.
Distribution
Worldwide - US Nationwide distribution in the states of CA, CO, FL, GA, HI, IL, IN, LA, MA, MD, NC, NJ, NY, PA, TN, TX, VA, WA the country of Canada.
Initiated
Voluntary: Firm initiated
Recall number
Z-3089-2026

Ongoing Class I Medical devices

Recall started
6 May 2026
Reason
These procedure kits contain Bupivacaine Hydrochloride in Dextrose Injection, USP. The manufacturer of the Bupivacaine, Huons Co, Ltd., has issued a voluntary recall due to potential quality issues identified during a recent FDA manufacturing facility inspection.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2277-2026, Z-2276-2026, Z-2278-2026

Ongoing Class I Drugs

Recall started
28 April 2026
Reason
Presence of Particulate Matter.
Distribution
U.S.A. Nationwide
Initiated
Voluntary: Firm initiated
Recall number
D-0540-2026

Ongoing Class II Drugs

Recall started
2 April 2026
Reason
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
Distribution
US Nationwide.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0496-2026, D-0498-2026, D-0497-2026, D-0495-2026

Ongoing Class I Medical devices

Recall started
19 March 2026
Reason
Potential for the accumulation of small air bubbles in the arterial line due to adherence of blood gases to the tubing under negative pressure.
Distribution
Worldwide distribution - US Nationwide and the country of Canada.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1801-2026, Z-1798-2026, Z-1800-2026, Z-1803-2026, Z-1802-2026, Z-1799-2026

Ongoing Class II Medical devices

Recall started
2 February 2026
Reason
The potential for the needle tip to be dull/blunt, difficult to advance, and/or break.
Distribution
Worldwide - US Nationwide distribution in the state of TX and the country of Costa Rica.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1483-2026, Z-1482-2026, Z-1481-2026

Ongoing Class II Medical devices

Recall started
29 January 2026
Reason
B. Braun was notified by our supplier, Ferndale Laboratories, Inc., the manufacturer of MASTISOL¿ Liquid Adhesive, that they have issued a voluntary recall due to potential cracking of the butyrate tubing (outside tube), which renders the product unusable.
Distribution
US Nationwide distribution in the states of AL, FL, PA, TX, VA, WA.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2266-2026, Z-2263-2026, Z-2269-2026, Z-2265-2026, Z-2264-2026, Z-2267-2026, Z-2268-2026, Z-2270-2026

Ongoing Class II Medical devices

Recall started
29 October 2025
Reason
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Distribution
Worldwide distribution - US distribution and international distribution to Canada, Germany, Guatemala, and Singapore.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0617-2026, Z-0656-2026, Z-0616-2026, Z-0712-2026, Z-0647-2026, Z-0607-2026, Z-0640-2026, Z-0639-2026, Z-0679-2026, Z-0705-2026, Z-0675-2026, Z-0651-2026 and 104 more

Ongoing Class I Medical devices

Recall started
30 September 2025
Reason
The potential for micro-air bubbles observed in the bloodline and air-in-line alarms due to damaged arterial and venous patient connectors.
Distribution
Domestic: US Nationwide Distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-0070-2026

Ongoing Class II Medical devices

Recall started
18 September 2025
Reason
Potential for the lid of the catheter connector to be in the incorrect position.
Distribution
Nationwide distribution to AK, AL, AR, AZ, CA, CO, FL, GA, HI, IA, IL, IN, KS, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NJ, NM, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0116-2026, Z-0125-2026, Z-0123-2026, Z-0115-2026, Z-0122-2026, Z-0114-2026, Z-0126-2026, Z-0120-2026, Z-0124-2026, Z-0119-2026, Z-0118-2026, Z-0117-2026 and 1 more

Ongoing Class II Drugs

Recall started
26 August 2025
Reason
Lack of Assurance of Sterility- Potential for fluid leakage from the port due to port misalignment.
Distribution
U.S. Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
D-0653-2025, D-0652-2025

Ongoing Class I Drugs

Recall started
18 August 2025
Reason
Presence of Particulate Matter.
Distribution
U.S.A. Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
D-0628-2025, D-0627-2025

Ongoing Class II Drugs

Recall started
4 August 2025
Reason
Lack of Assurance of Sterility; potential for fluid leakage at one of the weld sites.
Distribution
Nationwide in the US
Initiated
Voluntary: Firm initiated
Recall numbers
D-0586-2025, D-0585-2025

Ongoing Class I Medical devices

Recall started
9 July 2025
Reason
Label is incorrect. The product label indicates that the device contains an air eliminating filter. However, the filter utilized on this extension set is not indicated for removal of air and does not feature an air vent, which is common to air eliminating filters.
Distribution
US distribution to AZ, CA, CO, CT, FL, GA, HI, IL, IN, KS, MA, MD, ME, MI, MN, MO, MS, NC, NJ, NV, NY, OH, OR, PA, SC, SD, TN, TX, UT, VA, WA, WY. International distribution to Canada.
Initiated
Voluntary: Firm initiated
Recall number
Z-2176-2025

Ongoing Class II Drugs

Recall started
16 June 2025
Reason
Lack of assurance of sterility: pinholes, within the finger boxes used during Form Fill Seal process resulting in leaks.
Distribution
USA Nationwide
Initiated
Voluntary: Firm initiated
Recall number
D-0491-2025

Ongoing Class II Drugs

Recall started
31 March 2025
Reason
Presence of Particulate Matter
Distribution
Product was distributed to 12 distributors who may have further distributed the product nationwide.
Initiated
Voluntary: Firm initiated
Recall number
D-0353-2025

Ongoing Class II Medical devices

Recall started
17 February 2025
Reason
Increased risk for valve housing detachment causing leakage.
Distribution
Domestic: CA, CA, FL, GA, IL, IL, IN, MD, MN, MO, NC, NM, NY, PA, TN, TX, VA, and WA; Foreign: Canada.
Initiated
Voluntary: Firm initiated
Recall number
Z-1397-2025

Ongoing Class II Medical devices

Recall started
4 December 2024
Reason
Incorrect catheter connector within the kit resulting in inability to provide a secure connection to the epidural catheter. The incorrect catheter connector is smaller than the required catheter connector and therefore is unable to be used to administer medication.
Distribution
US Nationwide distribution in the states of MO, OK.
Initiated
Voluntary: Firm initiated
Recall number
Z-1021-2025

Ongoing Class II Medical devices

Recall started
15 August 2024
Reason
Incomplete insertion of the patient connector of the Streamline Airless System Hemodialysis Bloodline to the Locksite may result in the potential for occlusion during prograde rinseback procedures. If the patient connector is not fully inserted into the Locksite, the internal septum may not open fully enough to prevent restrictions to flow. may cause delays in therapy while clinicians are forced to switch to retrograde flow method
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-3173-2024, Z-3175-2024, Z-3174-2024, Z-3178-2024, Z-3177-2024, Z-3176-2024, Z-3179-2024

Ongoing Class II Medical devices

Recall started
8 August 2024
Reason
Potential for product leakage from the Spin Lock Connector on the distal end of the device due to the migration of excess solvent during the assembly process.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall number
Z-3144-2024

Ongoing Class I Medical devices

Recall started
7 August 2024
Reason
Extension of previous recall RES 92978. Pumps have the potential for upstream occlusion sensor to cease proper function due to buildup of electrostatic charge during operation triggering false downstream and upstream occlusion alarms. Additional devices have been affected.
Distribution
US distribution to AL, CA, GA, IL, MI, and TX.
Initiated
Voluntary: Firm initiated
Recall number
Z-2972-2024

Ongoing Class I Drugs

Recall started
24 July 2024
Reason
Presence of Particulate Matter
Distribution
Nationwide within U.S.A
Initiated
Voluntary: Firm initiated
Recall number
D-0638-2024

Ongoing Class II Medical devices

Recall started
17 June 2024
Reason
Potential for the backcheck valve to malfunction, resulting in backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime, resulting in patient injuries of adverse drug reaction and/or product malfunction with loss of medication/blood.
Distribution
Worldwide distribution - US Nationwide and the country of Canada.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2404-2024, Z-2392-2024, Z-2380-2024, Z-2390-2024, Z-2391-2024, Z-2395-2024, Z-2386-2024, Z-2384-2024, Z-2389-2024, Z-2388-2024, Z-2383-2024, Z-2381-2024 and 17 more

Ongoing Class II Medical devices

Recall started
14 June 2024
Reason
Perfusor Space Syringe Pump's instructions for use previously identified Monoject syringes as an option for use. However, changes to manufacturing to Cardinal Health Monoject syringes may result in issues with recognition, compatibility, and pump performance, such as overdose, underdose, delay in therapy, delay in occlusion alarms, and delay in feeding. Cardinal Health Monoject syringes are not compatible with the indicated pumps.
Distribution
Domestic distribution nationwide. International distribution to Canada.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2434-2024, Z-2435-2024, Z-2436-2024, Z-2433-2024, Z-2437-2024

Ongoing Class II Medical devices

Recall started
17 May 2024
Reason
The devices are labeled "not made with DEHP" or the DEHP free symbol; however, the glue used contains traces of DEHP.
Distribution
Worldwide distribution - US Nationwide and the country of Canada.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2131-2024, Z-2132-2024, Z-2134-2024, Z-2133-2024

Terminated Class II Drugs

Recall started
22 March 2024
Terminated
1 July 2025
Reason
Lack of assurance of sterility: bags have the potential to leak..
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall number
D-0431-2024

Terminated Class II Drugs

Recall started
6 March 2024
Terminated
16 April 2025
Reason
Lack of assurance of sterility: pinholes, within the blue label characters on the EXCEL bag, specifically within the dotted characters on the label, resulting in leaks.
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall number
D-0370-2024

Ongoing Class II Medical devices

Recall started
22 January 2024
Reason
Kits should contain Filter Straws with Standard Luer Connections however, the kits contain Filter Straws with Neuraxial connectors preventing interface with the other components of the kit.
Distribution
US Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1150-2024, Z-1149-2024

Ongoing Class I Medical devices

Recall started
1 November 2023
Reason
In affected products, the tubing outer diameter may vary in size or the length of tubing may be too short. Both issues may lead to false air-in-line alarms, which will stop the infusion and interrupt therapy. Interruptions or delays in medication administration may result in serious injury to patients which may be life-threatening (e.g. interruption of a vasopressor to a hemodynamically unstable patient) or may lead to death.
Distribution
Distribution US nationwide, Canada and Germany.
Initiated
Voluntary: Firm initiated
Recall number
Z-0355-2024

Ongoing Class II Medical devices

Recall started
26 September 2023
Reason
Devices may leak as a result of a manufacturing issue. Leakage may result in a delay of therapy, increase risk of bloodstream infection (BSI), and may expose both patients and healthcare workers to hazardous medication. There is also the potential for life-threatening situations to occur requiring additional medical intervention.
Distribution
Worldwide distribution - US Nationwide and the countries of Canada and Singapore.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0132-2024, Z-0133-2024, Z-0131-2024, Z-0130-2024, Z-0135-2024, Z-0134-2024, Z-0128-2024, Z-0129-2024, Z-0136-2024

Ongoing Class I Medical devices

Recall started
21 September 2023
Reason
Upstream occlusion alarm may sound when no occlusion exists, and the device will stop pumping. Interruption to the infusion of high-risk medications may lead to hemodynamic instability requiring medical intervention to prevent permanent impairment to body structures or body functions. In some cases, this may be life-threatening or may lead to death.
Distribution
Domestic distribution nationwide. Foreign distribution to Canada.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0123-2024, Z-0124-2024

Ongoing Class II Medical devices

Recall started
7 August 2023
Reason
The sterile blister packaging may be damaged, and sterility may be compromised
Distribution
US Nationwide distribution in the state of VA.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2644-2023, Z-2643-2023

Terminated Class III Drugs

Recall started
2 August 2023
Terminated
7 July 2025
Reason
Labeling: Not Elsewhere Classified - the description, warnings, storage information and instructions for use are either missing or partially printed.
Distribution
United States
Initiated
Voluntary: Firm initiated
Recall number
D-1083-2023

Ongoing Class II Medical devices

Recall started
31 July 2023
Reason
Product may be mislabeled with an incorrect lid stock label.
Distribution
US Distributions to states of - AR, AZ, CA, FL, GA, IL, MA, MO, NC, NJ, PA, TX, WA
Initiated
Voluntary: Firm initiated
Recall number
Z-2627-2023

Terminated Class II Drugs

Recall started
5 July 2023
Terminated
23 April 2024
Reason
Lack of assurance of sterility: bags have the potential to leak.
Distribution
USA Nationwide
Initiated
Voluntary: Firm initiated
Recall number
D-0916-2023

Ongoing Class II Medical devices

Recall started
5 June 2023
Reason
Kits were assembled with the incorrect Filter Straw.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2003-2023, Z-2002-2023

Terminated Class II Drugs

Recall started
9 May 2023
Terminated
14 March 2024
Reason
Subpotent: Low anti-factor IIa Potency.
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall number
D-0579-2023

Terminated Class II Drugs

Recall started
1 March 2023
Terminated
13 March 2024
Reason
Subpotent Drug: low Anti-Factor IIa potency.
Distribution
Nationwide in the USA
Recall number
D-0434-2023

Completed Class II Drugs

Recall started
10 February 2023
Reason
Lack of sterility assurance: Recall of certain batches of 0.9% Sodium Chloride for Injection USP in EXCEL¿ Plus IV Container product due to the possibility of an incomplete seal that may cause leakage. The impacted lots may exhibit microscopic channel leaks near the port assembly of the product.
Distribution
USA Nationwide.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0347-2023, D-0346-2023

Terminated Class II Drugs

Recall started
25 November 2022
Terminated
23 August 2024
Reason
Lack of sterility assurance: Bags have the potential to leak.
Distribution
FL, NJ, PA
Initiated
Voluntary: Firm initiated
Recall number
D-0076-2023

Ongoing Class II Medical devices

Recall started
15 September 2022
Reason
The extension set has a high probability of potential failure which could lead to possible leakage or detachment at the device's bonded joint during use. The issue may result in delay of therapy, increased risk of bloodstream infections (BSI), and may expose both patients and healthcare workers to hazardous medications. Depending on the nature of the leak and type of infusion, there is also the potential for life-threatening situations to occur including air embolization or hypovolemia.
Distribution
Distribution US nationwide, Canada and Saudi Arabia.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0092-2023, Z-0090-2023, Z-0091-2023

Ongoing Class II Medical devices

Recall started
1 September 2022
Reason
Potential for leakage at the catheter hub.
Distribution
Domestic distribution to AZ CA FL GA MD MI MO MS NC NY OH PA TN TX WA. Foreign distribution to Canada
Initiated
Voluntary: Firm initiated
Recall number
Z-0009-2023

Terminated Class II Drugs

Recall started
25 February 2022
Terminated
16 March 2023
Reason
Lack of sterility assurance: leaking bags
Distribution
USA Nationwide
Initiated
Voluntary: Firm initiated
Recall number
D-0655-2022

Terminated Class II Medical devices

Recall started
7 February 2022
Terminated
28 December 2023
Reason
Units not properly inspected prior to release to the market, may not function as indicated in the product labeling, resulting in syringe detection and infusion accuracy that can result in delays in therapy, overinfusion, or underinfusion.
Distribution
US Distribution to states of: MA, VT
Initiated
Voluntary: Firm initiated
Recall number
Z-0819-2022

Terminated Class II Medical devices

Recall started
31 January 2022
Terminated
29 April 2024
Reason
This lot may have an elevated risk of leakage from the Air-Inlet Filter of the device. Leakage of the Air-Inlet Filter may increase the risk of decreasing the dose of medication delivered to the patient, cause delays in treatment due to the need to replace the device or may cause contamination of the fluid path that can lead to bloodstream infection.
Distribution
US Nationwide distribution in the states of AZ, CA, FL, LA, MI, MO, MS, NC, NJ, OH, PA, TN, TX, and UT. The country of Canada.
Initiated
Voluntary: Firm initiated
Recall number
Z-0727-2022

Terminated Class II Medical devices

Recall started
28 January 2022
Terminated
15 May 2024
Reason
Firm learned of the potential for cracks to form in the conductivity sensors during use, which may lead to a leak in the dialysate circuit. This could result in excessive ultrafiltration or insufficient ultrafiltration depending on whether the dialysis machine is equipped with a Dialysis Fluid filter.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0873-2022, Z-0872-2022

Terminated Class II Medical devices

Recall started
10 August 2021
Terminated
16 September 2024
Reason
Leakage of the pump set within the cassette portion of the pump sets, potential for delays in administration of medications, under-delivery or incomplete dosing and bloodstream infections.
Distribution
Worldwide distribution - US Nationwide distribution and the country of Canada.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2555-2021, Z-2549-2021, Z-2544-2021, Z-2559-2021, Z-2557-2021, Z-2552-2021, Z-2553-2021, Z-2547-2021, Z-2560-2021, Z-2550-2021, Z-2548-2021, Z-2551-2021 and 5 more

Terminated Class II Medical devices

Recall started
25 June 2021
Terminated
16 October 2023
Reason
There is a potential for the Anti-free flow clip of the administration set to be inverted which may cause unintended free flow if the user fails to follow on screen prompt to close the roller clamp prior to set removal from the pump.
Distribution
Affected products were distributed to the following US states: CA, MI, OR, and UT.
Initiated
Voluntary: Firm initiated
Recall number
Z-2137-2021

Terminated Class II Medical devices

Recall started
15 March 2021
Terminated
7 June 2022
Reason
BBMI has identified through complaints the potential for the extension set to become occluded or unable to prime.
Distribution
US Nationwide distribution in the states of NC, CA.
Initiated
Voluntary: Firm initiated
Recall number
Z-1509-2021

Terminated Class II Medical devices

Recall started
23 November 2020
Terminated
14 March 2023
Reason
There is the potential for the compounding system to not immediately interrupt compounding and alert user to the presence of an air bubble exceeding 3% of the ordered volume for an ingredient. This could result in a a compounded drug that does not meet the specified accuracy range for an individual ingredient.
Distribution
US Nationwide distribution including in the states of AL, AZ, CA, CO, CT, FL, GA, IA, IL, LA, MA, MD, MI, MN, MO, NC, NH, NJ, NV, NY, OH, OK, PA, TN,TX, WA.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0718-2021, Z-0717-2021, Z-0719-2021

Terminated Class I Drugs

Recall started
18 April 2020
Terminated
21 October 2021
Reason
Failed Stability Specifications: Out-of-Specification (OOS) results for High Molecular Weight Polymers.
Distribution
Product was distributed nationwide within the United States.
Initiated
Voluntary: Firm initiated
Recall number
D-1257-2020

Terminated Class II Medical devices

Recall started
20 November 2019
Terminated
16 October 2020
Reason
Potential for leakage at the joint between the blood filters and tubing
Distribution
US Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0938-2020, Z-0936-2020, Z-0939-2020, Z-0937-2020, Z-0941-2020, Z-0940-2020, Z-0935-2020

Terminated Class II Medical devices

Recall started
10 July 2019
Terminated
21 August 2020
Reason
The filter capacity is not achieved due to damage of the filter membrane.
Distribution
CA FL MO TX MN AL GA NC IL PA
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2470-2019, Z-2466-2019, Z-2471-2019, Z-2474-2019, Z-2472-2019, Z-2469-2019, Z-2473-2019, Z-2468-2019, Z-2467-2019

Terminated Class II Drugs

Recall started
13 June 2019
Terminated
15 July 2022
Reason
Subpotent Drug: low out-of-specification results were identified for the drug anti-factor IIa potency which is intended to ensure that the potency of heparin is within the USP specifications.
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall number
D-1343-2019

Terminated Class I Medical devices

Recall started
1 May 2019
Terminated
13 July 2020
Reason
Potential for the Infusion Pump Administration Set to leak and/or disconnect at the bonded joint between the tubing and Injection Site (Y-Site).
Distribution
Distribution to US state of TX, and Canada.
Initiated
Voluntary: Firm initiated
Recall number
Z-2489-2019

Terminated Class II Medical devices

Recall started
20 July 2018
Terminated
13 May 2020
Reason
The catheter connectors may not stay closed during in and in some cases, leakage or disconnection of the catheters from the catheter connectors has been observed.
Distribution
Worldwide Distribution: US (nationwide) and countries of: Australia, Canada, Guatemala and Kuwait.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-3341-2018, Z-3345-2018, Z-3314-2018, Z-3331-2018, Z-3370-2018, Z-3367-2018, Z-3383-2018, Z-3316-2018, Z-3343-2018, Z-3356-2018, Z-3361-2018, Z-3320-2018 and 81 more

Terminated Class II Medical devices

Recall started
4 June 2018
Terminated
13 January 2020
Reason
There is a potential for valves on the 26-Lead Transfer Set to be incorrectly oriented. When a transfer set with an incorrectly oriented valve is installed on the system, there is potential for unintended admixture.
Distribution
The products were distributed to the following US states: AL, CA, CO, CT, FL, GA, IL, LA, MA, MD, MI, MN, MO, NC, NJ, NV, OH, PA, TX, and WA.
Initiated
Voluntary: Firm initiated
Recall number
Z-2343-2018

Terminated Class II Medical devices

Recall started
9 May 2018
Terminated
12 December 2019
Reason
There is a potential for a different set to be mixed within the lot, where the incorrect set does not contain an air eliminating filter.
Distribution
US Distribution to the states of : CA, IL, and TX., and Internationally to Canada.
Initiated
Voluntary: Firm initiated
Recall number
Z-2285-2018

Terminated Class II Drugs

Recall started
16 February 2018
Terminated
23 January 2020
Reason
Presence of Particulate Matter: Customer complaint of particulate matter which has been identified as polyethylene, which is consistent with the material used to manufacture the container cap was received.
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall number
D-0549-2018

Terminated Class II Medical devices

Recall started
21 June 2017
Terminated
3 April 2018
Reason
B. Braun Medical Inc. (BBMI) initiated this recall of various BBMI convenience kits containing the 22GA 1-1/2in SafetyGlide Needle due to the presence of loose polypropylene foreign matter was above release specification. This foreign matter has been identified as a product hub material which has been tested for biocompatibility per ISO 10993 during the product development process.
Distribution
US Nationwide Distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0573-2018, Z-0567-2018, Z-0570-2018, Z-0572-2018, Z-0568-2018, Z-0571-2018, Z-0574-2018, Z-0569-2018, Z-0575-2018, Z-0576-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.